Ad is loading...
MENU

APVO Aptevo Therapeutics Forecast, Technical & Fundamental Analysis

a provider of immunology and cancer research services

Industry Biotechnology
APVO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
APVO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

APVO is expected to report earnings to fall 96.35% to -43 cents per share on May 09

Aptevo Therapeutics APVO Stock Earnings Reports
Q1'24
Est.
$-0.44
Q4'23
Missed
by $11.52
Q3'23
Missed
by $21.36
Q2'23
Missed
by $53.00
Q1'23
Beat
by $1.61
The last earnings report on March 06 showed earnings per share of -1193 cents, missing the estimate of -40 cents. With 769.57K shares outstanding, the current market capitalization sits at 3.91M.
A.I. Advisor
published General Information

General Information

a provider of immunology and cancer research services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 4th Avenue
Phone
+1 206 838-0500
Employees
40
Web
https://www.aptevotherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VEL19.95-0.03
-0.15%
Velocity Financial
DOX83.98-1.73
-2.02%
Amdocs Limited
MYRG146.81-3.53
-2.35%
MYR Group
SSSS4.82-0.21
-4.17%
SuRo Capital Corp
SNES2.52-0.14
-5.40%
SenesTech Inc.

APVO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, APVO has been loosely correlated with GOSS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if APVO jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APVO
1D Price
Change %
APVO100%
-12.45%
GOSS - APVO
42%
Loosely correlated
-3.88%
CYTK - APVO
36%
Loosely correlated
-8.19%
ENLV - APVO
36%
Loosely correlated
-0.93%
VINC - APVO
34%
Loosely correlated
-1.57%
AXON - APVO
33%
Loosely correlated
-0.86%
More